BACKGROUND: Sepsis most often presents to the ED, and delayed detection is harmful. WBC count is often used to detect sepsis, but changes in WBC count size also correspond to sepsis. We sought to determine if volume increases of circulating immune cells add value to the WBC count for early sepsis detection in the ED.
Sepsis contributes significantly to hospital resource utilization and patient mortality. [1] [2] [3] Approximately 70% of sepsis cases are admitted through the ED, 4 and delays in the identification and treatment of these patients contribute significantly to adverse outcomes. [5] [6] [7] Whereas the definition of sepsis was recently revised (Sepsis-3) based on systemic manifestations that portend adverse outcomes, 8 most hospital deaths because of sepsis occur in those presenting with milder sepsis, as reflected by Sepsis-2 criteria. 3, 5 A standard approach to identifying sepsis includes a clinical suspicion of infection coupled with systemic inflammatory response syndrome (SIRS) criteria, and this approach is shown to perform well relative to Sepsis-3 criteria for predicting hospital mortality or ICU transfer. 9 Therefore, the criteria used for the older Sepsis-2 definition performs well in the ED population for predicting adverse sepsis outcomes, and presumably identifies those who would most benefit from early treatment.
In response to the new Sepsis-3 definition, the Surviving Sepsis Campaign 10 recommends that the identification and treatment of sepsis should be unchanged, with the first essential step being to identify suspected infection.
The early detection and treatment of sepsis remains a major clinical challenge. The detection of infection is typically delayed by > 4 h after admission to the hospital 11 and by > 8 h in approximately 30% of cases presenting to the ED. 12 Unlike other sepsis biomarkers, such as procalcitonin (PCT) or C-reactive protein (CRP), the WBC count is among the first laboratory tests available to clinicians in the ED. As such, PCT and CRP are not typically used for early detection. Unfortunately, WBC count elevation is nonspecific for sepsis in the ED patient population. 13 Therefore, there is a pressing need for a biomarker that is routinely available during the initial ED clinical evaluation to enhance the detection of sepsis.
Circulating neutrophils and monocytes are among the first to respond to pathogenic organisms. 14 Recent studies suggest that immune cell volume increases may be useful for the detection of sepsis. [14] [15] [16] [17] [18] [19] [20] [21] These recent studies, although encouraging, are limited by their small sample sizes and did not include patients in the ED. Therefore, we sought to determine the utility of measuring volumetric changes of circulating immune cells as predictors of sepsis in a large prospective study of adult patients in the ED. We hypothesized that volume increases in circulating neutrophils and/or monocytes, alone or in combination with other established CBC parameters, such as WBC count, would improve sepsis detection in the ED.
Methods

Patient Enrollment
The study, registered with ClinicalTrials.gov (NCT02232750) and approved by the Western Institutional Review Board, Inc (Protocol No. 20141542), was a blinded, prospective cohort study enrolling patients presenting to two different EDs at the Ohio State University Wexner Medical Center. The study enrolled adults ($ 18-90 years of age) whose initial evaluation included a CBC within 24 h of admission to the ED, and no subject was enrolled more than once. Based on available literature, 4, 22 we estimated that approximately 1,350 study subjects in the ED with concurrent CBC testing would be required to achieve the lower limits of 65% for the target sensitivity estimate of 75% using a two-sided 95% CI. These calculations were based on the approach recommended by Burderer. 23 Given the large volume of admissions to the two EDs, we enrolled patients using a weekday cap of 25 consecutive patients per day.
WBC Volume Determination
All blood samples were analyzed on a UniCel DxH 800 analyzer (Beckman Coulter, Inc) with version 2.0 software within 8 h of collection. This instrument measures specific cell volume parameters and the distribution of cell volumes within a group of cells (Fig 1) (Cell volume parameters [mean neutrophil volume (MNV), neutrophil distribution width (NDW), mean monocyte volume (MMV), and monocyte distribution width (MDW)] are research use parameters on the DxH 800; their clinical utility has not been established. These parameters are not yet approved for use as sepsis biomarkers.) The clinical research team was blinded to the results at the time of clinical data entry and during assignment of the patients to a clinical category.
Clinical Classification of Patients in the ED
Study subjects were categorized as follows based on the Sepsis-2 consensus criteria: 24, 25 non-SIRS (ie, zero or one SIRS criterion) and no infection; SIRS (two or more SIRS criteria); sepsis (infection plus SIRS); severe sepsis (sepsis with one or more organ failure); septic shock (sepsis with refractory hypotension); and infection, but no sepsis (ie, zero or one SIRS criterion). SIRS criteria are as follows: WBC > 12,000 or < 4,000 or > 10% bands, pulse > 90 beats per minute, respiratory rate > 20 breaths per minute, and temperature < 96.8 F or > 100.4 F. The presence of infection was determined using all available clinical data available 7 days after ED admission, including results from cultures, molecular tests (eg, polymerase chain reaction, antigens), relevant imaging, and tissue pathology.
Sepsis criteria had to be fulfilled within 6 h of the CBC count, and categorization (as previously discussed) was verified by expert review of the electronic medical record > 7 days after ED admission by two investigators (E. D. C. and D. R. C.). Discordances were adjudicated, and a final determination was made by one investigator (E. D. C.) prior to data analysis.
Preexisting Conditions
We anticipated that certain clinical conditions could confound the results of the study. For example, vitamin deficiencies (eg, B12, folate), primary bone marrow disorders, and certain drugs are common causes of generalized macrocytosis. 26 Furthermore, immune chestjournal.org suppression could suppress immune cell activation and associated changes in morphology. As such, we performed independent analyses of the data wherein we considered preexisting conditions known to cause macrocytosis or to be associated with impaired immune cell activation (e- Table 1 ) to determine if these preexisting conditions independently influenced the study results.
Statistical Approach
General descriptive statistics and box plots were calculated for cell population distribution parameters. Diagnostic ability was evaluated in terms of the area under the curve (AUC), sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) along with their 95% CIs. The score approach was used to calculate CIs for sensitivity, specificity, PPV, and NPV. The initial cutoff values were obtained using the Youden index approach, which were optimized iteratively to maximize the sensitivity and specificity.
Three approaches were used to demonstrate the added value of MDW in comparison with WBC count. The first was the differences in AUCs. The AUC was calculated using a one-predictor variable logistic model with WBC count as the predictor and sepsis status as the response. In addition, the AUC was calculated for the twopredictor variables logistic model with both WBC count and MDW as predictors and sepsis as response. The comparison between the AUC from the two models (WBC count vs WBC count þ MDW) along with their CIs were calculated as described by De Long et al. 27 The second was the Cochran-Mantel-Haenszel (CMH) approach. Both WBC count and MDW were dichotomized to 0 and 1 based on their values falling into the normal or abnormal category. WBC count was considered to be normal if the recovered value was between 3.6 and 12.0. MDW was considered to be normal when its recovered value was < 20.5. CMH statistics and the common OR for MDW adjusted for WBC count effects were calculated as previously described. 28 MDW provided added value if the estimated OR was statistically different from 1 (ie, the 95% CI did not include 1). The third was the decision curve analysis. The number of true positives (TP) and false positives (FP) were calculated from the two logistic models (WBC count alone and WBC count þ MDW). The net benefit for a given probability (p, 0 # p # 1) was calculated for each model as follows:
Where N is the total number of subjects in the trial, and p is the threshold probability. Decision curves (net benefit vs threshold probability) were plotted for each model and compared with each other.
29,30 SAS 9.3 (SAS Institute) was used for data analyses.
Results
Patient Demographics
From September 2014 through December 2014, 1,320 patients were enrolled. Demographic features of the patients are shown in e- Table 2 . Approximately 30% of the sepsis cases were admitted through a community hospital ED in eastern Columbus, Ohio; approximately 70% were admitted to the ED of a larger tertiary hospital located near the center of the city. The distribution of control subjects and subjects with SIRS, infection, sepsis, severe sepsis, and septic shock is provided in Table 1 . The prevalence of sepsis in this ED population was 7.4%, with severe sepsis or septic shock accounting for 18.8% of the patients with sepsis (1.4% of the total ED population). In keeping with other sepsis studies, 31 more than one-half of the patients with sepsis (61%) had positive cultures (blood, urine, or other body fluids), with the rest being diagnosed based on clinical criteria (eg, surgical tissue analysis), serological testing, or polymerase chain reaction testing. Among those with positive cultures, diagnostic serologies, or polymerase chain reaction results, the causes of sepsis were categorized as follows: 79% bacterial, 14% viral, and 7% fungal.
Detection of Sepsis Based on Cell Volume Criteria
Four independent variables, as well as routine CBC count parameters, were analyzed for their ability to identify patients with sepsis (all sepsis phenotypes were combined for this analysis: sepsis, severe sepsis, and septic shock) in the ED population: MNV, NDW (a measure of size variation within the cell population), MMV, and MDW (e- Table 3 , Fig 1) . Neutrophil parameters MNV and NDW were significantly higher in the sepsis group compared with all others, as was the case for monocyte parameters MMV and MDW (Fig 2) . Although WBC count and the WBC neutrophil percentage were higher in the sepsis group, these parameters were also elevated in the SIRS group (e -Fig 1) . After establishing cutoff values best discriminating sepsis from the other conditions for each parameter (e- Table 4) , we compared the discrimination of each for sepsis. Overall, MDW best discriminated sepsis from all other conditions based on the AUC (e- Table 5 ). The NPV of a normal MDW was 97%.
The performance of MDW was slightly better when subjects with preexisting conditions associated with macrocytosis or compromised immune cell function, comprising approximately 17% of the total study population, were excluded from the analysis (e- Table 6 ).
Correlation of MDW With Infection Severity
As shown in e- Figure 2 , MDW increases incrementally with progression from milder forms of infection to sepsis, and is highest in those with more organ dysfunction in sepsis.
MDW Added Value Analysis for Sepsis Detection
The estimated AUC for WBC count was 0.81 (95% CI, 0.75-0.86) and for MDW þ WBC count was 0.89 (95% CI, 0.84-0.92). The difference between the AUCs of the two models was 0.08 (95% CI, 0.02-0.13). The CMH OR was 6.9 (95% CI, 4.2-11.4). The benefit of MDW is reflected when the difference between AUCs is significantly > 0 and the CMH OR is significantly > 1. Inclusion of MDW with WBC count provided an 8% improvement on the AUC (Fig 3A) , with P ¼ .0035, and by CMH OR (95% CIs are > 1). Because both criteria were satisfied, the MDW contribution to improved sepsis detection is statistically significant. Although the same assumptions cannot be made for comparisons of the AUC of sepsis and SIRS, MDW is shown to have a higher AUC alone, and in combination with WBC count, compared with WBC count alone ( Fig 3B) . As shown in Figure 4 , the MDW improves sepsis detection relative to WBC count alone across a wide range of decision probability thresholds.
Discussion
Volumetric increases are an early manifestation of immune cell responses to severe infections and as such have shown potential as sepsis biomarkers in humans. [14] [15] [16] [17] [18] [19] [20] [21] We show that volumetric changes of circulating immune cells, particularly increased MDW, correspond with previously established criteria for sepsis 24 in a large patient population in the ED. MDW distinguished sepsis from SIRS, and the magnitude of MDW elevation correlated with infection severity and organ dysfunction, ranging from normal MDW in those with limited infections, and increasing incrementally with sepsis severity. Moreover, the MDW provides added value relative to WBC count alone for early detection of sepsis in the ED. To the extent that earlier detection of sepsis leads to earlier treatment, these findings have implications for reducing sepsis mortality.
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Consistent with the results of recent human studies, [14] [15] [16] [17] [18] [19] [20] [21] and the established function of neutrophils as first responders during the innate immune response to invading organisms, both MNV and NDW were reasonably sensitive and specific for the detection of Fig 3B) . We posit that monocyte parameters may perform better because circulating monocytes are first responders to infections, 33, 34 and the response is proportional to the intensity of the exposure to either bacterial, fungal, or viral pathogens, 35 resulting in an acute increase in monocyte size. 36, 37 In contrast, the neutrophil response to certain infections (eg, viral 38, 39 ) is relatively delayed.
The ED population is most appropriate for sepsis screening given that most sepsis cases cared for in the hospital setting meet sepsis criteria at the time of admission, 4 and early identification of sepsis is critical in terms of clinical outcomes. [5] [6] [7] By recent estimates, > 500,000 cases of severe sepsis, or about two-thirds of all severe sepsis cases, present to the ED each year in the United States. 1, 4 This number would be even higher if milder cases of sepsis had been considered, and patients presenting with less severe sepsis make up most of sepsis deaths. 1, 3 In keeping with previous studies, 4, 22 we found that a minority (7.4%) of ED admissions present with sepsis, and that SIRS of noninfectious etiology was approximately two times more prevalent than sepsis.
Although this study was not designed to compare monocyte and neutrophil volumetric parameters with all other available sepsis biomarkers, MDW is shown to provide added value to WBC count, the biomarker most commonly used to screen for sepsis in the ED. Three different approaches demonstrated added value of MDW in comparison with WBC count alone. 30 The area under the receiver operator characteristic curve is often criticized because it provides an overall measure of diagnostic ability and is limited in terms of the detection of positive and negative patients, 30 and the 
Net Benefit
Threshold Probability Figure 4 -Decision probability curves for sepsis detection reflecting the added value of MDW compared with WBC count alone. The net benefit of WBC count alone (blue line) and in combination with MDW (red line) for the detection of sepsis was calculated over a range of pretest probabilities for sepsis (see Methods for details). The control (gray line) represents a model that provides no insight into the diagnosis of sepsis. MDW þ WBC count show greater benefit than WBC count alone over a wide range of sepsis probabilities (2%-70%). The models converge > 70% sepsis probability, a situation that is not representative of the ED population. See Figure 2 legend for expansion of abbreviation. There are several limitations of the study. First, there is no gold standard for the diagnosis of sepsis, and misclassification of sepsis and nonsepsis SIRS inevitably limits the accuracy of the biomarker. 42 Furthermore, it is unclear how the MDW will perform for the newly established Sepsis-3 criteria. 8 In that regard, it is notable that a subgroup of patients with more severe sepsis presentations (ie, equivalent to Sepsis-3) had the highest MDW values (e -Fig 2) , and Sepsis-2 criteria (SIRS) may be superior to Sepsis-3 criteria for identifying high risk patients in non-ICU populations. 9 A larger study is needed to confirm that MDW results can be standardized across multiple sites using multiple instruments and to determine if MDW þ WBC count perform better when monitored over time. Ultimately, it will be important to determine how the availability of the MDW influences the management of sepsis in the ED, including early and appropriate antibiotic treatments, and sepsis-related clinical outcomes, such as hospital and ICU lengths of stay, morbidity (eg, organ failures), and mortality. The study was conducted over a 4-month period spanning the fall and early winter seasons during which a seasonal effect on sepsis was evident (more cases in late fall/early winter), emphasizing the diversity of sepsis cases and the need to consider how the test performs in each sepsis subset based on the infectious etiology (eg, viral, bacterial, fungal). Finally, host factors, as shown in e- Table 1 , could influence the immune cell volumetric analysis. Whereas the inclusion of these preexisting conditions (present in 17% of patients in the ED) in our data analysis had only a small effect on the overall study results (e -Table 6 ), the effects of these factors may need to be considered on a case-by-case basis in the ED setting.
Conclusions
This study shows that the MDW, a measure of a change in the size distribution of circulating monocytes, provides significant added value to WBC count for the detection of sepsis in the ED population. From a practical perspective, when validated by a larger prospective study, incorporation of MDW and WBC count parameters during initial CBC count analysis could be readily used in the ED to provide a timely and convenient sepsis diagnostic tool and lead to early initiation of antimicrobial therapy.
